These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 6063421)

  • 1. [Influence of chloroquine and hydroxychloroquine on the evolution of postischemic movement disorders].
    Rosner I; Malhie P
    Therapie; 1967; 22(2):345-54. PubMed ID: 6063421
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effect of antirheumatic drugs on adjuvant-induced polyarthritis in rats.
    Ward JR; Cloud RS
    J Pharmacol Exp Ther; 1966 Apr; 152(1):116-21. PubMed ID: 5937395
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.
    Wallace DJ
    Lupus; 1996 Jun; 5 Suppl 1():S59-64. PubMed ID: 8803913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychloroquine versus chloroquine in polymorphic light eruption.
    Singh G; Archana G
    Indian J Dermatol Venereol Leprol; 2008; 74(4):396-7. PubMed ID: 18797074
    [No Abstract]   [Full Text] [Related]  

  • 5. [Macular leprosy of Lucio--antimalarials in leprotic reaction].
    Padilla HC
    Dermatol Int; 1965; 4(3):147-50. PubMed ID: 5877280
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of hydroxychloroquine and chloroquine during treatment of rheumatic diseases.
    Furst DE
    Lupus; 1996 Jun; 5 Suppl 1():S11-5. PubMed ID: 8803904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lupus erythematosus tumidus: response to antimalarial treatment in 36 patients with emphasis on smoking.
    Kreuter A; Gaifullina R; Tigges C; Kirschke J; Altmeyer P; Gambichler T
    Arch Dermatol; 2009 Mar; 145(3):244-8. PubMed ID: 19289751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rheumatologist's verdict on the safety of chloroquine versus hydroxychloroquine. Liability in off-label prescribing.
    Houpt JB
    J Rheumatol; 1999 Sep; 26(9):1864-6. PubMed ID: 10493661
    [No Abstract]   [Full Text] [Related]  

  • 9. Tissue distribution of chloroquine and hydroxychloroquine in rats.
    Grundmann M; Ríhová D; Lukásová D; Vrublovský P
    Acta Univ Palacki Olomuc Fac Med; 1982; 102():99-105. PubMed ID: 6242589
    [No Abstract]   [Full Text] [Related]  

  • 10. The interaction between aminoquinolines and presynaptically acting neurotoxins.
    Simpson LL
    J Pharmacol Exp Ther; 1982 Jul; 222(1):43-8. PubMed ID: 6283072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of antimalarial drugs for the treatment of psoriatic arthritis.
    Sayers ME; Mazanec DJ
    Am J Med; 1992 Oct; 93(4):474-5. PubMed ID: 1415314
    [No Abstract]   [Full Text] [Related]  

  • 12. An ophthalmological view on the efficacy and safety of chloroquine versus hydroxychloroquine.
    Easterbrook M
    J Rheumatol; 1999 Sep; 26(9):1866-8. PubMed ID: 10493662
    [No Abstract]   [Full Text] [Related]  

  • 13. Are 1-2 dangerous? Chloroquine and hydroxychloroquine exposure in toddlers.
    Smith ER; Klein-Schwartz W
    J Emerg Med; 2005 May; 28(4):437-43. PubMed ID: 15837026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine and chloroquine: assessing the risk of retinal toxicity.
    Aylward JM
    J Am Optom Assoc; 1993 Nov; 64(11):787-97. PubMed ID: 8120333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short report: chloroquine-resistant Plasmodium vivax in the Republic of Korea.
    Lee KS; Kim TH; Kim ES; Lim HS; Yeom JS; Jun G; Park JW
    Am J Trop Med Hyg; 2009 Feb; 80(2):215-7. PubMed ID: 19190216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells.
    van den Borne BE; Dijkmans BA; de Rooij HH; le Cessie S; Verweij CL
    J Rheumatol; 1997 Jan; 24(1):55-60. PubMed ID: 9002011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kikuchi-Fujimoto disease: hydroxychloroquine as a treatment.
    Rezai K; Kuchipudi S; Chundi V; Ariga R; Loew J; Sha BE
    Clin Infect Dis; 2004 Dec; 39(12):e124-6. PubMed ID: 15578393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydroxychloroquine in pregnant patients with systemic lupus erythematosus.
    Parke A; West B
    J Rheumatol; 1996 Oct; 23(10):1715-8. PubMed ID: 8895146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial therapy in SLE.
    Lanham JG; Hughes GR
    Clin Rheum Dis; 1982 Apr; 8(1):279-98. PubMed ID: 6749400
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of necrobiosis lipoidica with antimalarial agents.
    Durupt F; Dalle S; Debarbieux S; Balme B; Ronger S; Thomas L
    Arch Dermatol; 2008 Jan; 144(1):118-9. PubMed ID: 18209184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.